SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla informs about Outcome of Board Meeting

21 Jul 2015 Evaluate

Cipla has informed that the Board of Directors of the Company at its meeting held on July 20, 2015, approved a potential investment by FIL Capital Investments (Mauritius) II Limited, or any of its affiliate in a wholly owned subsidiary of Cipla Limited (proposed to be incorporated) to whom Cipla will be divesting its consumer healthcare business on a going-concern basis. The approval is subject to execution of binding agreements, and the transaction will be subject to relevant regulatory approvals. None of the persons belonging to Promoter / Promoter Group(s) of the Company has any interest in the transaction.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1238.30 7.55 (0.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×